Clinical Roundup SignalChem, Merck to evaluate SLC-391 + Keytruda in phase II study of advanced NSCLC March 26, 2021Vol.47 No.12
Clinical Roundup SWOG study: Cancer trial participation does not eliminate disparities for poor patients March 19, 2021Vol.47 No.11
Clinical Roundup Trial of tilsotolimod + ipilimumab in anti-PD-1 refractory advanced melanoma fails to meet ORR March 19, 2021Vol.47 No.11
Clinical Roundup Aveo, BMS collaborate on phase III trial of Fotivda + Opdivo in IO relapsed RCC March 19, 2021Vol.47 No.11
Clinical Roundup Hopkins study: Cancer immunotherapy approach targets common genetic alteration March 19, 2021Vol.47 No.11
Clinical Roundup UAB’s Cancer Center, GO2 Foundation for Lung Cancer initiate STRIDES study to increase African American participation in lung cancer trials March 19, 2021Vol.47 No.11
Clinical Roundup New targeted agent achieves nearly 30% response rate in trial with patients with uterine serous carcinoma March 19, 2021Vol.47 No.11
Clinical Roundup NCCN provides COVID-19 treatment advice; updates vaccine guidance for cancer patients March 12, 2021Vol.47 No.10
Clinical Roundup UNC Lineberger review demonstrates benefits and harms from LDCT screening March 12, 2021Vol.47 No.10
Clinical Roundup National cancer genetic screening program at Emory offers at-home testing March 12, 2021Vol.47 No.10
